Abstract
Excellent Outcome in <i>NPM1-</i>mutated Acute Myeloid Leukemia Patients Receiving Intensified Fludarabine-Based Induction Is Not Affected By Secondary Type Mutations and Other High Risk Aberrations
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have